TY - JOUR AU - Ciulla, T. A. AU - Amador, A. G. AU - Zinman, B. PY - 2003 DA - 2003// TI - Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.9.2653 DO - 10.2337/diacare.26.9.2653 ID - Ciulla2003 ER - TY - JOUR AU - Ding, J. AU - Wong, T. Y. PY - 2012 DA - 2012// TI - Current epidemiology of diabetic retinopathy and diabetic macular edema JO - Curr Diabetes Rep VL - 12 UR - https://doi.org/10.1007/s11892-012-0283-6 DO - 10.1007/s11892-012-0283-6 ID - Ding2012 ER - TY - JOUR AU - Wang, W. AU - Lo, A. C. Y. PY - 2018 DA - 2018// TI - Diabetic retinopathy: pathophysiology and treatments JO - Int J Mol Sci VL - 19 UR - https://doi.org/10.3390/ijms19061816 DO - 10.3390/ijms19061816 ID - Wang2018 ER - TY - JOUR AU - Yau, J. W. AU - Rogers, S. L. AU - Kawasaki, R. PY - 2012 DA - 2012// TI - Global prevalence and major risk factors of diabetic retinopathy JO - Diabetes Care VL - 35 UR - https://doi.org/10.2337/dc11-1909 DO - 10.2337/dc11-1909 ID - Yau2012 ER - TY - JOUR AU - Boyer, D. S. AU - Hopkins, J. J. AU - Sorof, J. AU - Ehrlich, J. S. PY - 2013 DA - 2013// TI - Anti-vascular endothelial growth factor therapy for diabetic macular edema JO - Ther Adv Endocrinol Metab VL - 4 UR - https://doi.org/10.1177/2042018813512360 DO - 10.1177/2042018813512360 ID - Boyer2013 ER - TY - JOUR AU - Klein, R. AU - Klein, B. E. AU - Moss, S. E. PY - 1984 DA - 1984// TI - The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema JO - Ophthalmology VL - 91 UR - https://doi.org/10.1016/S0161-6420(84)34102-1 DO - 10.1016/S0161-6420(84)34102-1 ID - Klein1984 ER - TY - JOUR AU - Chen, E. AU - Looman, M. AU - Laouri, M. PY - 2010 DA - 2010// TI - Burden of illness of diabetic macular edema: literature review JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007995.2010.482503 DO - 10.1185/03007995.2010.482503 ID - Chen2010 ER - TY - JOUR AU - Shea, A. M. AU - Curtis, L. H. AU - Hammill, B. G. PY - 2008 DA - 2008// TI - Resource use and costs associated with diabetic macular edema in elderly persons JO - Arch Ophthalmol VL - 126 UR - https://doi.org/10.1001/archopht.126.12.1748 DO - 10.1001/archopht.126.12.1748 ID - Shea2008 ER - TY - JOUR AU - Ford, J. A. AU - Lois, N. AU - Royle, P. PY - 2013 DA - 2013// TI - Current treatments in diabetic macular oedema: systematic review and meta-analysis JO - BMJ Open VL - 3 UR - https://doi.org/10.1136/bmjopen-2012-002269 DO - 10.1136/bmjopen-2012-002269 ID - Ford2013 ER - TY - JOUR AU - Nguyen, Q. D. AU - Brown, D. M. AU - Marcus, D. M. PY - 2012 DA - 2012// TI - Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE JO - Ophthalmology VL - 119 UR - https://doi.org/10.1016/j.ophtha.2011.12.039 DO - 10.1016/j.ophtha.2011.12.039 ID - Nguyen2012 ER - TY - JOUR AU - Brown, D. M. AU - Nguyen, Q. D. AU - Marcus, D. M. PY - 2013 DA - 2013// TI - Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE JO - Ophthalmology VL - 120 UR - https://doi.org/10.1016/j.ophtha.2013.02.034 DO - 10.1016/j.ophtha.2013.02.034 ID - Brown2013 ER - TY - JOUR AU - Brown, D. M. AU - Schmidt-Erfurth, U. AU - Do, D. V. PY - 2015 DA - 2015// TI - Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies JO - Ophthalmology VL - 122 UR - https://doi.org/10.1016/j.ophtha.2015.06.017 DO - 10.1016/j.ophtha.2015.06.017 ID - Brown2015 ER - TY - JOUR AU - Wykoff, C. C. AU - Le, R. T. AU - Khurana, R. N. PY - 2017 DA - 2017// TI - Outcomes with as-needed aflibercept and macular laser following the phase III VISTA DME trial: ENDURANCE 12-month extension study JO - Am J Ophthalmol VL - 173 UR - https://doi.org/10.1016/j.ajo.2016.09.029 DO - 10.1016/j.ajo.2016.09.029 ID - Wykoff2017 ER - TY - JOUR AU - Midena, E. AU - Gillies, M. AU - Katz, T. A. PY - 2018 DA - 2018// TI - Impact of baseline central retinal thickness on outcomes in the VIVID-DME and VISTA-DME studies JO - J Ophthalmol VL - 2018 UR - https://doi.org/10.1155/2018/3640135 DO - 10.1155/2018/3640135 ID - Midena2018 ER - TY - JOUR AU - Haritoglou, C. AU - Kook, D. AU - Neubauer, A. PY - 2006 DA - 2006// TI - Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema JO - Retina VL - 26 UR - https://doi.org/10.1097/01.iae.0000247165.38655.bf DO - 10.1097/01.iae.0000247165.38655.bf ID - Haritoglou2006 ER - TY - JOUR AU - VanderBeek, B. L. AU - Shah, N. AU - Parikh, P. C. AU - Ma, L. PY - 2016 DA - 2016// TI - Trends in the care of diabetic macular edema: analysis of a national cohort JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0149450 DO - 10.1371/journal.pone.0149450 ID - VanderBeek2016 ER - TY - JOUR AU - Trivedi, P. J. AU - Tickle, J. AU - Vesterhus, M. N. PY - 2018 DA - 2018// TI - Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner JO - Gut VL - 67 UR - https://doi.org/10.1136/gutjnl-2016-312354 DO - 10.1136/gutjnl-2016-312354 ID - Trivedi2018 ER - TY - JOUR AU - Weston, C. J. AU - Shepherd, E. L. AU - Claridge, L. C. PY - 2015 DA - 2015// TI - Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis JO - J Clin Invest VL - 125 UR - https://doi.org/10.1172/JCI73722 DO - 10.1172/JCI73722 ID - Weston2015 ER - TY - JOUR AU - Luo, W. AU - Xie, F. AU - Zhang, Z. AU - Sun, D. PY - 2013 DA - 2013// TI - Vascular adhesion protein 1 in the eye JO - J Ophthalmol VL - 2013 ID - Luo2013 ER - TY - JOUR AU - Murata, M. AU - Noda, K. AU - Fukuhara, J. PY - 2012 DA - 2012// TI - Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy JO - Invest Ophthalmol Vis Sci VL - 53 UR - https://doi.org/10.1167/iovs.12-9857 DO - 10.1167/iovs.12-9857 ID - Murata2012 ER - TY - JOUR AU - Abu El-Asrar, A. M. AU - Alam, K. AU - Garcia-Ramirez, M. PY - 2017 DA - 2017// TI - Association of HMGB1 with oxidative stress markers and regulators in PDR JO - Mol Vis VL - 23 ID - Abu El-Asrar2017 ER - TY - JOUR AU - Yoshida, S. AU - Murata, M. AU - Noda, K. PY - 2018 DA - 2018// TI - Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells JO - Jpn J Ophthalmol VL - 62 UR - https://doi.org/10.1007/s10384-017-0555-4 DO - 10.1007/s10384-017-0555-4 ID - Yoshida2018 ER - TY - JOUR AU - Noda, K. AU - Miyahara, S. AU - Nakazawa, T. PY - 2008 DA - 2008// TI - Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis JO - FASEB J VL - 22 UR - https://doi.org/10.1096/fj.07-9377com DO - 10.1096/fj.07-9377com ID - Noda2008 ER - TY - JOUR AU - Noda, K. AU - Nakao, S. AU - Zandi, S. PY - 2009 DA - 2009// TI - Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes JO - Exp Eye Res VL - 89 UR - https://doi.org/10.1016/j.exer.2009.07.010 DO - 10.1016/j.exer.2009.07.010 ID - Noda2009 ER - TY - JOUR AU - Matsuda, T. AU - Noda, K. AU - Murata, M. PY - 2017 DA - 2017// TI - Vascular adhesion protein-1 blockade suppresses ocular inflammation after retinal laser photocoagulation in mice JO - Invest Ophthalmol Vis Sci VL - 58 UR - https://doi.org/10.1167/iovs.17-21555 DO - 10.1167/iovs.17-21555 ID - Matsuda2017 ER - TY - JOUR AU - Grover, S. AU - Murthy, R. K. AU - Brar, V. S. AU - Chalam, K. V. PY - 2009 DA - 2009// TI - Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis) JO - Am J Ophthalmol VL - 148 UR - https://doi.org/10.1016/j.ajo.2009.03.006 DO - 10.1016/j.ajo.2009.03.006 ID - Grover2009 ER - TY - JOUR AU - Ibrahim, M. A. AU - Sepah, Y. J. AU - Symons, R. C. PY - 2012 DA - 2012// TI - Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edema JO - Eye (Lond) VL - 26 UR - https://doi.org/10.1038/eye.2011.293 DO - 10.1038/eye.2011.293 ID - Ibrahim2012 ER - TY - JOUR AU - Campochiaro, P. A. AU - Khanani, A. AU - Singer, M. PY - 2016 DA - 2016// TI - Enhanced benefit in diabetic macular edema from AKB-9778 Tie2 activation combined with vascular endothelial growth factor suppression JO - Ophthalmology VL - 123 UR - https://doi.org/10.1016/j.ophtha.2016.04.025 DO - 10.1016/j.ophtha.2016.04.025 ID - Campochiaro2016 ER -